In KRAS mutant CRC cell lines, levels of 5-hydroxymethylcytosine (a DNA methylation marker) were reduced, implying a decrease in DNA demethylation, which was reversed by the ablation of GC1 or KRAS mutant. This evidence concerns the gene SLC25A22 and colorectal carcinoma.